181 related articles for article (PubMed ID: 18676852)
21. Implication of scatter/growth factors in tumor progression.
Boyer B; Vallés AM; Jouanneau J; Delouvée A; Thiery JP
Princess Takamatsu Symp; 1994; 24():233-42. PubMed ID: 8983078
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
Cheng CJ; Wu YC; Shu JA; Ling TY; Kuo HC; Wu JY; Chang EE; Chang SC; Huang YH
J Biomed Sci; 2007 Nov; 14(6):797-807. PubMed ID: 17682839
[TBL] [Abstract][Full Text] [Related]
23. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA; Bahrami AR
Int J Cancer; 2007 Apr; 120(7):1598-602. PubMed ID: 17205510
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Int J Urol; 2006 Apr; 13(4):415-9. PubMed ID: 16734861
[TBL] [Abstract][Full Text] [Related]
25. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
[TBL] [Abstract][Full Text] [Related]
26. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer.
Lodillinsky C; Rodriguez V; Vauthay L; Sandes E; Casabé A; Eiján AM
J Urol; 2009 Aug; 182(2):749-55. PubMed ID: 19539312
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
28. [Expression of OCT4 protein in bladder cancer and its clinicopathological implications].
Zhao P; Liu C; Xu K; Zheng S; Li H; Xu Y; Xu A; Li B; Huang P
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):643-6. PubMed ID: 22588915
[TBL] [Abstract][Full Text] [Related]
29. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
30. Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor.
Wang P; Nishitani MA; Tanimoto S; Kishimoto T; Fukumori T; Takahashi M; Kanayama HO
Urology; 2007 Apr; 69(4):780-4. PubMed ID: 17445681
[TBL] [Abstract][Full Text] [Related]
31. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of alpha-defensin is associated with bladder cancer invasiveness.
Holterman DA; Diaz JI; Blackmore PF; Davis JW; Schellhammer PF; Corica A; Semmes OJ; Vlahou A
Urol Oncol; 2006; 24(2):97-108. PubMed ID: 16520271
[TBL] [Abstract][Full Text] [Related]
33. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
34. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
35. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
36. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
37. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
Hursting SD; Perkins SN; Lavigne JA; Beltran L; Haines DC; Hill HL; Alvord WG; Barrett JC; DiGiovanni J
Mol Carcinog; 2009 Aug; 48(8):671-7. PubMed ID: 19415693
[TBL] [Abstract][Full Text] [Related]
38. From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion.
Trosko JE
Ann N Y Acad Sci; 2006 Nov; 1089():36-58. PubMed ID: 17261754
[TBL] [Abstract][Full Text] [Related]
39. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
Satoh M; Ito A; Nojiri H; Handa K; Numahata K; Ohyama C; Saito S; Hoshi S; Hakomori SI
Int J Oncol; 2001 Oct; 19(4):723-31. PubMed ID: 11562747
[TBL] [Abstract][Full Text] [Related]
40. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.
Lee J; Kim HK; Han YM; Kim J
Int J Biochem Cell Biol; 2008; 40(5):1043-54. PubMed ID: 18191611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
